Home Page

Leading Cell & Gene Therapy CRO/CDMO
Proprietary gene editing & stem cell technology platforms to advance broader cell therapy manufacturing, disease modeling, and bioproduction.

Our Company

As a leading cell and gene therapy CRO/CDMO, Applied StemCell is a proud supporter of gene editing and stem cell therapy development. With two high-impact platforms, CRISPR/TARGATT™ Genome Editing and iPSC (GMP grade), we seek to help advance the development of novel therapeutics.